HLS Insider Trading

Insider Ownership Percentage: 1.72%
Insider Buying (Last 12 Months): A$303,795.99
Insider Selling (Last 12 Months): A$0.00

Healius Insider Trading History Chart

This chart shows the insider buying and selling history at Healius by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Healius Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for HLS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Healius Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2023Kathryn (Kate) McKenzieInsiderBuy53,000A$1.52A$80,560.00
12/1/2023Michael StanfordInsiderBuy32,468A$1.54A$49,838.38
9/11/2023Jennifer (Jenny) MacdonaldInsiderBuy8,000A$2.53A$20,232.00
9/4/2023John MattickInsiderBuy7,547A$3.31A$25,003.21
8/31/2023Maxine JaquetInsiderExercise41,066A$2.80A$114,984.80
5/30/2023Maxine JaquetInsiderIssued371,859A$3.12A$1,160,200.08
3/10/2023John MattickInsiderBuy7,546A$3.31A$24,999.90
2/28/2023Jennifer (Jenny) MacdonaldInsiderBuy37,500A$2.75A$103,162.50
11/11/2022Gordon DavisInsiderIssued24,150A$3.31A$80,008.95
10/25/2022Malcolm ParmenterInsiderSell200,000A$3.30A$660,200.00
9/27/2022Jennifer (Jenny) MacdonaldInsiderBuy10,000A$3.33A$33,300.00
9/20/2022Jennifer (Jenny) MacdonaldInsiderBuy25,000A$3.43A$85,750.00
9/14/2022John MattickInsiderBuy8,312A$3.63A$30,172.56
9/9/2022John MattickInsiderBuy19,230A$3.65A$70,151.04
9/5/2022Kathryn (Kate) McKenzieInsiderBuy10,500A$3.63A$38,115.00
9/2/2022Malcolm ParmenterInsiderExpiry36,938A$3.62A$133,715.56
7/1/2022Malcolm ParmenterInsiderIssued101,034A$3.65A$368,774.10
11/19/2021Jennifer (Jenny) MacdonaldInsiderIssued12,048A$4.98A$59,999.04
11/8/2021Malcolm ParmenterInsiderSell143,193A$4.98A$713,101.14
10/26/2021Kathryn (Kate) McKenzieInsiderBuy2,000A$4.99A$9,980.00
10/20/2021Malcolm ParmenterInsiderIssued101,034A$4.55A$459,704.70
9/6/2021Malcolm ParmenterInsiderExercise724,482A$5.00A$3,622,410.00
9/1/2021Jennifer (Jenny) MacdonaldInsiderBuy10,000A$4.98A$49,800.00
2/25/2021Robert HubbardInsiderExercise7,172A$3.48A$24,980.08
See Full Table

SEC Filings (Institutional Ownership Changes) for Healius (ASX:HLS)

77.94% of Healius stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Healius logo
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Read More on Healius

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


2,327,215 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Healius?

Healius' top insider investors include:
  1. Gordon Davis (Insider)
  2. Jennifer (Jenny) Macdonald (Insider)
  3. John Mattick (Insider)
  4. Kathryn (Kate) McKenzie (Insider)
  5. Malcolm Parmenter (Insider)
  6. Maxine Jaquet (Insider)
  7. Michael Stanford (Insider)
Learn More about top insider investors at Healius.